Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes

We investigated for the first time the effect of combination therapy of renin–angiotensin system inhibition (RASi) and sodium–glucose co-transporter-2 inhibitors (SGLT2is) on endotrophin (ETP), a pro-fibrotic signaling molecule reflecting collagen type VI formation, measured in the plasma of persons...

Descripción completa

Detalles Bibliográficos
Autores principales: Møller, Alexandra Louise, Thöni, Stefanie, Keller, Felix, Sharifli, Samir, Rasmussen, Daniel Guldager Kring, Genovese, Federica, Karsdal, Morten Asser, Mayer, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669010/
https://www.ncbi.nlm.nih.gov/pubmed/38002084
http://dx.doi.org/10.3390/biomedicines11113084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669010/
https://www.ncbi.nlm.nih.gov/pubmed/38002084
http://dx.doi.org/10.3390/biomedicines11113084

Ejemplares similares